A rising multiple dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of orally administered SCH 900389 in healthy females (P07036)
Completed
- Conditions
- infertility10013356
- Registration Number
- NL-OMON36461
- Lead Sponsor
- Schering-Plough
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 52
Inclusion Criteria
Healthy female subjects
Exclusion Criteria
Clinical significant abnormalities at screening
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>To investigate the safety and tolerability of the test compound after multiple<br /><br>oral dose administration for up to14 days<br /><br><br /><br>To investigate the pharmacodynamic effects of the test compound after multiple<br /><br>dose oral administration for up to 14 days</p><br>
- Secondary Outcome Measures
Name Time Method <p>*To investigate the multiple dose pharmacokinetics of the test compound</p><br>